Immunoassay-Based Analyses Detect No Significant Changes in Plasma FABP3, GFAP, and Aβ Levels but a Significant Difference in Aβ42/Aβ40 Ratio Between PTSD and Other Diagnostic Groups. The gene discussed is FABP3; the disease is post-traumatic stress disorder.